India to South Korea: Melphalan Export Trade Route
India has recorded 4 verified shipments of Melphalan exported to South Korea, representing a combined trade value of $269.5K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $67.4K USD. The leading Indian exporter is EMCURE PHARMACEUTICALS LIMITED, which accounts for 100% of total export value with 4 shipments worth $269.5K USD. On the buying side, ACE PHARMA CO. LTD. is the largest importer in South Korea with $269.4K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to South Korea Melphalan corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $269.5K USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's melphalan manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $67.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with melphalan's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 12.7%, placing it at rank #8 among India's top melphalan export destinations globally.
On the import side, key buyers of Indian melphalan in South Korea include ACE PHARMA CO. LTD., ACE PHARMA. ACE PHARMA CO. LTD. is the single largest importer with 2 shipments valued at $269.4K USD.
Route Characteristics
- Average transit16 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#8
- Annual growth+12.7%
- Demand growth+13.0%
- Regulatory ease72/100
Top 10 Indian Melphalan Exporters to South Korea
Showing top 10 of 1 Indian suppliers exporting Melphalan to South Korea, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED Avg $67.4K per shipment | 4 | $269.5K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting melphalan to South Korea, ranked by total trade value. The listed exporters are: EMCURE PHARMACEUTICALS LIMITED. EMCURE PHARMACEUTICALS LIMITED is the dominant supplier with 4 shipments worth $269.5K USD, giving it a 100% market share.
Top 10 Melphalan Importers in South Korea
Showing top 10 of 2 known buyers in South Korea receiving Melphalan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian melphalan in South Korea include ACE PHARMA CO. LTD., ACE PHARMA. The largest importer is ACE PHARMA CO. LTD., accounting for $269.4K USD across 2 shipments — representing 100% of all melphalan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACE PHARMA CO. LTD. | 2 | $269.4K | 100.0% |
| 2 | ACE PHARMA | 2 | $121 | 0.0% |
Top 10 Melphalan Formulations Imported by South Korea
Showing top 10 of 4 product formulations shipped on the India to South Korea Melphalan route, ranked by trade value
South Korea imports a wide range of melphalan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMACEUTICALS PRODUCTS(FINISHED PRODUCT)MEGVAL 50MG INJ 1VIAL(MELPHALAN HYDROCHLORIDE FOR INJECTION 50MG/VIAL) — accounts for $269.4K USD across 1 shipments. A total of 4 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICALS PRODUCTS(FINISHED PRODUCT)MEGVAL 50MG INJ 1VIAL(MELPHALAN HYDROCHLORIDE FOR INJECTION 50MG/VIAL) | 1 | $269.4K | 100.0% |
| 2 | MELPHALAN HCI FOR INJECTION 50MG BASE/VIAL 2.5ML | 1 | $61 | 0.0% |
| 3 | STERILE DILUENT FOR MELPHALAN HCI FOR INJECTION 50MG BASE/VIAL | 1 | $61 | 0.0% |
| 4 | FOC PHARMACEUTICALS PRODUCTS(FINISHED PRODUCT)MEGVAL 50MG INJ 1VIAL(MELPHALAN HYDROCHLORIDE FOR INJECTION 50MG/VIAL) | 1 | $0 | 0.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 70%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 2 shipments. Transit time averages 16 days by sea.
Market Dynamics
India's melphalan exports to South Korea are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in South Korea benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $67.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as melphalan hci for injection 50mg base/vial 2.5ml and sterile diluent for melphalan hci for injection 50mg base/vial, suggesting that buyers in South Korea tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACE PHARMA CO. LTD. is the largest importer with 2 shipments worth $269.4K USD — representing 100% of all melphalan imports from India on this route.
Route Statistics
- Trade Volume
- $269.5K
- Avg. Shipment
- $67.4K
- Suppliers
- 1
- Buyers
- 2
- Transit (Sea)
- ~16 days
- Annual Growth
- +12.7%
Other Melphalan Routes
Unlock the Full India to South Korea Melphalan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 4 shipments on this route.
Frequently Asked Questions — India to South Korea Melphalan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Melphalan to South Korea?
The leading Indian exporters of Melphalan to South Korea are EMCURE PHARMACEUTICALS LIMITED. EMCURE PHARMACEUTICALS LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Melphalan exports from India to South Korea?
India exports Melphalan to South Korea worth approximately $269.5K USD across 4 recorded shipments. The average value per shipment is $67.4K USD.
Q Which ports does India use to ship Melphalan to South Korea?
The most active port of origin is SAHAR AIR with 2 shipments. Indian exporters primarily use sea freight for this route, with 70% of shipments going by sea and 19% by air.
Q How long does shipping take from India to South Korea for Melphalan?
The average transit time for Melphalan shipments from India to South Korea is approximately 16 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to South Korea Melphalan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.7% with demand growth tracking at 13.0%. The route is ranked #8 among India's top Melphalan export destinations globally.
Q How many suppliers are active on the India to South Korea Melphalan route?
There are currently 1 active Indian suppliers exporting Melphalan to South Korea. The market is moderately concentrated with EMCURE PHARMACEUTICALS LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Melphalan from India in South Korea?
The leading importers of Indian Melphalan in South Korea include ACE PHARMA CO. LTD., ACE PHARMA. ACE PHARMA CO. LTD. is the largest buyer with 2 shipments worth $269.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to South Korea export trade corridor identified from Indian Customs (DGFT) records for Melphalan.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 2 importers in South Korea matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 4 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists